促红细胞生成素血清铁网织红细胞平均血红蛋白含量联合检测在老年肾性贫血治疗中应用价值.docVIP

促红细胞生成素、血清铁、网织红细胞平均血红蛋白含量联合检测在老年肾性贫血治疗中的应用价值 　　[摘要] 目的 探究肾性贫血老年患者临床通过检测血清铁（FE）、促红细胞生成素（EPO）、网织红细胞平均血红蛋白含量（CHr）判断疾病治疗情况的可行性。方法 本次疾病组患者选取我院2014年6月～2016年6月期间门诊部门收治的106例肾性贫血老年患者，同时选取70例相同时间入院行健康检查且结果为正常的受检者为对比组，清晨空腹抽取所有研究对象静脉血，比较对比组与疾病组指标（FE、CHr、EPO）水平差异，同时对疾病组进行相应用药治疗，在疗程结束后再次抽取样血，观察治疗前后患者指标水平变化。结果 入院时对比组FE、CHr、EPO水平明显高于疾病组，同时用药后疾病组FE、CHr、EPO水平明显高于治疗前（P0.05）。结论 临床评估肾性贫血老年患者疾病治疗效果，可以检测患者血液中FE、CHr、EPO水平变化，这三种联合用于疾病诊断、治疗效果评估，准确度高。 　　[关键词] 肾性贫血；血清铁；检测；促红细胞生成素 　　[中图分类号] R556 [文献标识码] A [文章编号] 2095-0616（2017）07-131-03 　　Application value of combined detection of erythropoietin， serum iron and reticulocyte hemoglobin content in the treatment of senile anemia 　　LIN Jinsong1 YUAN Huiqing1 ZHANG Wenhua2 　　1. Changan Hospital， Dongguan 523000， China； 2. The Eighth Peoples Hospital， Dongguan 523000， China 　　[Abstract] Objective To explore the feasibility of of judging the treatment of anemia in elderly patients with renal anemia by detecting the serum iron （FE）， erythropoietin （EPO）， and the mean corpuscular hemoglobin （CHr）. Methods 106 cases of elderly patients with renal anemia cured in outpatient department of our hospital from June 2014 to June 2016 were selected. At the same time， 70 patients， who admitted to the hospital for health examination and the results were normal subjects， were selected as control group. Fasting blood samples were taken from all subjects in the morning. Index （FE， CHr， EPO） level difference of control group and disease group were compared. At the same time， patients in disease group were treated with the corresponding drugs， and the blood samples were taken again after the course of treatment. Results The levels of FE， CHr and EPO in the control group were significantly higher than those in the disease group， and the levels of FE， CHr and EPO in the disease group were significantly higher than those before treatment（P0.05）. Conclusion By detecting the changes of FE， CHr and EPO in the blood of patients， Clinical effect of elderly patients wit